Press Releases

BEDFORD, Mass., Sept. 19, 2019 /PRNewswire/ -- Instrumentation Laboratory (IL) today announced commercialization of the HemosIL AcuStar ADAMTS13 Activity Assay in the European Union and other international markets.  For use on the ACL AcuStar® Hemostasis Testing System, this fully automated, chemiluminescent immunoassay offers clinicians rapid, on-demand A

OMAHA, Neb. and TAMPA, Fla., Sept. 19, 2019 /PRNewswire/ -- WellCare of Nebraska, Inc., a WellCare Health Plans, Inc. (NYSE: WCG) company, announced it has named Robert B. Rhodes, M.D., chief medical officer. In this role, Dr. Rhodes oversees the plan's medical strategy and

VANCOUVER, Sept. 19, 2019 /PRNewswire/ - Harvest One Cannabis Inc. ("Harvest One" or the "Company") (TSX-V: HVT; OTCQX: HRVOF) congratulates Burb for earning their first two retail cannabis licences in Port Coquitlam, British Columbia. Harvest One owns 19.9% of Burb which is the maximum allowed under

BALTIMORE, Sept. 19, 2019 /PRNewswire/ -- Y-Trap, Inc. has signed a collaboration and license agreement with Merck KGaA, Darmstadt, Germany, a leading science and technology company, for the exclusive development of multiple specific antibody-ligand traps for cancer immunotherapy.The collaboration leverages Y-Trap's proprietary pl

EDISON, N.J., Sept. 19, 2019 /PRNewswire/ -- Lily Bioceuticals™, a research-based anti-aging skin care and cosmetics manufacturer announces the launch of BEYOND FLAWLESS™ SECOND SKIN, the first viable 24-hour breathable, water proof, life-like cosmetic synthetic skin to diminish eye bags & wrinkles.   For decades scientists have promis

SALT LAKE CITY, Sept. 19, 2019 /PRNewswire/ -- USANA, a leader in cellular nutrition, is honored to announce its Coenzyme Q10 (CoQ10) supplement —

SOUTH SAN FRANCISCO, Calif., Sept. 19, 2019 /PRNewswire/ -- Portola Pharmaceuticals, Inc. (Nasdaq: PTLA) today announced the appointment of Ted W. Love, M.D., to its Board of Directors. Dr. Love is a recognized industry leader with more than 25 years of experience in the discovery and development of high impact medicines.

CAMBRIDGE, Mass., and NEW YORK, Sept. 19, 2019 /PRNewswire/ -- Black Diamond Therapeutics, Inc., a precision oncology medicine company pioneering the discovery and development of small molecule, tumor-agnostic therapies, today announced the appointment of Christopher D. Roberts, Ph.D., as Chief Scientific O

SAN DIEGO, Sept. 19, 2019 /PRNewswire/ -- Trovagene, Inc. (Nasdaq: TROV), a clinical-stage, Precision Cancer Medicine™ oncology therapeutics company developing drugs that target cell division (mitosis), for the treatment of various cancers including leukemia, prostate and colorectal, today announced the successful completion of its Phase

BOLOGNA, Italy, Sept. 19, 2019 /PRNewswire/ -- Menarini Silicon Biosystems today announces the launch of the MSBiosuite, a cloud-based data analysis solution that completes the company workflow* for liquid biopsy and formalin-fixed paraffin embedded (FFPE) tissue analysis, and provides a powerful tool to bridge the gap between sequencing data and consolidated resul